Market Overview

UPDATE: JP Morgan Initiates Health Net with Neutral, $27 PT on the "State of Continuous Flux"

Related HNT
Mid-Afternoon Market Update: International Speedway Slips On Weak Results; Applied Genetic Technologies Shares Spike Higher
Mid-Day Market Update: US Stocks Down; Xoom Shares Jump On Acquisition News
Health Net (HNT) to Be Acquired by Centene for $6.8 Billion - Analyst Blog (Zacks)

JP Morgan initiates its coverage on Health Net (NYSE: HNT) with a Neutral rating and a price target of $27.

JP Morgan notes, "[Health Net] recent commercial cost misestimation and guide-down have highlighted the heightened underwriting and earnings volatility that accompanies single-state focused health insurers. Despite these concerns, Health Net remains an interesting asset given its sizable presence in California (~10% of that market), diversified business mix including TRICARE and the potential to improve upon industry-low margins. As a standalone business, Health Net has supplanted commercial enrollment declines with a growing Medicaid presence, positioning it well for the upcoming opportunity from Dual Eligible privatization, especially as California is home to more Dual Eligible beneficiaries than any other state. "

HNT closed at $$25.16 on Tuesday.

Latest Ratings for HNT

May 2015BarclaysMaintainsHold
Mar 2015BarclaysMaintainsUnderweight
Feb 2015BarclaysMaintainsUnderweight

View More Analyst Ratings for HNT
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Initiation Intraday Update Analyst Ratings


Related Articles (HNT)

Around the Web, We're Loving...

Get Benzinga's Newsletters